BioCentury
ARTICLE | Product Development

Conjoined against Conjunctivitis

May 11, 2009 7:00 AM UTC

By Mike Ward Senior Editor

Although treatment of allergic conjunctivitis is dominated by prescription antihistamines, generic steroids and over-the-counter products, Fovea Pharmaceuticals S.A. thinks its Prednisporin prednisolone/cyclosporine A combination will deliver enough improvement in symptom control and side effects to command premium pricing and capture 20% of the market...